Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2+ Breast Cancer
ClinicalTrials.gov study NCT00392392. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases
ClinicalTrials.gov study NCT01934894. IPD Sharing: Not stated. Countries: 1. Publications: 9.
A Study of the Safety of Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Early and Locally Advanced Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
ClinicalTrials.gov study NCT01940497. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Ca
ClinicalTrials.gov study NCT04214288. IPD Sharing: YES. Countries: 16. Publications: 2.
Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01827267. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer
ClinicalTrials.gov study NCT02129556. IPD Sharing: Not stated. Countries: 5. Publications: 5.
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT03262935. IPD Sharing: NO. Countries: 11. Publications: 1.
A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer
ClinicalTrials.gov study NCT04588298. IPD Sharing: YES. Countries: 3. Publications: 1.
Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer
ClinicalTrials.gov study NCT02689284. IPD Sharing: NO. Countries: 5. Publications: 2.
Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells
ClinicalTrials.gov study NCT01779050. IPD Sharing: NO. Countries: 1. Publications: 3.
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission
ClinicalTrials.gov study NCT02780401. IPD Sharing: NO. Countries: 1. Publications: 1.
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
ClinicalTrials.gov study NCT05950945. IPD Sharing: YES. Countries: 10. Publications: 1.
Compare Efficacy, Safety and Immunogenicity of HLX02 and Herceptin in Previously Untreated HER2 +Overexpressing Metastatic Breast Cancer
ClinicalTrials.gov study NCT03084237. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Her2-BATS and Pembrolizumab in Metastatic Breast Cancer
ClinicalTrials.gov study NCT03272334. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
ClinicalTrials.gov study NCT00391092. IPD Sharing: Not stated. Countries: 16. Publications: 1.
Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer
ClinicalTrials.gov study NCT01325428. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
ClinicalTrials.gov study NCT04466891. IPD Sharing: YES. Countries: 9. Publications: 2.
Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China
ClinicalTrials.gov study NCT03575065. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperativ
ClinicalTrials.gov study NCT01772472. IPD Sharing: Not stated. Countries: 28. Publications: 2.
A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or
ClinicalTrials.gov study NCT00875979. IPD Sharing: Not stated. Countries: 7. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.